Cooper Warren D
- SEC CIK
- 0001213897
No open-market purchases or sales filed in the past year.
Current role at each company
- ZYNE Zynerba Pharmaceuticals, Inc.Directoras of Oct 11, 2023
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Cooper Warren D as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jun 15, 2023 (view filing)4:28 PM ET | Jun 14 | 1 day | Cooper Warren DDirector | SSale | −115 | $0.3481 | −$40.03 | −0.2%75.8K after | |
| Jun 16, 2022 (view filing) | Jun 14 | 2 days | Cooper Warren DDirector | SSale | −40 | $1.01 | −$40.4 | −0.1%28.1K after |